Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis

被引：56

作者：

Miller, MB

Gilligan, PH

机构：

[1] Univ N Carolina Hosp, Clin Microbiol Immunol Labs, Chapel Hill, NC 27514 USA

[2] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA

[3] Univ N Carolina, Sch Med, Dept Microbiol, Chapel Hill, NC USA

[4] Univ N Carolina, Sch Med, Dept Immunol, Chapel Hill, NC USA

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2003年 / 41卷 / 09期

关键词：

D O I：

10.1128/JCM.41.9.4009-4015.2003

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：4009 / 4015

页数：7

共 42 条

[1] Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis [J].

Aaron, SD ;

Ferris, W ;

Ramotar, K ;

Vandemheen, K ;

Chan, F ;

Saginur, R .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (11) :4172-4179

[2] Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex -: Survival linked to genomovar type [J].

Aris, RM ;

Routh, JC ;

LiPuma, JJ ;

Heath, DG ;

Gilligan, PH .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (11) :2102-2106

[3] In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates - Comparison of the agar dilution method with the E-test and two agar diffusion methods [J].

Arpi, M ;

Victor, MA ;

Mortensen, I ;

Gottschau, A ;

Bruun, B .

APMIS, 1996, 104 (02) :108-114

[4] Comparison of agar diffusion methodologies for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients [J].

Burns, JL ;

Saiman, L ;

Whittier, S ;

Larone, D ;

Krzewinski, J ;

Liu, Z ;

Marshall, SA ;

JOnes, RN .

JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (05) :1818-1822

[5] Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis [J].

Burns, JL ;

Gibson, RL ;

McNamara, S ;

Yim, D ;

Emerson, J ;

Rosenfeld, M ;

Hiatt, P ;

McCcoy, K ;

Castile, R ;

Smith, AL ;

Ramsey, BW .

JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (03) :444-452

[6] Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis [J].

Burns, JL ;

Van Dalfsen, JM ;

Shawar, RM ;

Otto, KL ;

Garber, RL ;

Quan, JM ;

Montgomery, AB ;

Albers, GM ;

Ramsey, BW ;

Smith, AL .

JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (05) :1190-1196

[7] Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients [J].

Burns, JL ;

Saiman, L ;

Whittier, S ;

Krzewinski, J ;

Liu, ZL ;

Larone, D ;

Marshall, SA ;

Jones, RN .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 39 (04) :257-260

[8] Infection with Burkholderia cepacia in cystic fibrosis -: Outcome following lung transplantation [J].

Chaparro, C ;

Maurer, J ;

Gutierrez, C ;

Krajden, M ;

Chan, C ;

Winton, T ;

Keshavjee, S ;

Scavuzzo, M ;

Tullis, E ;

Hutcheon, M ;

Kesten, S .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (01) :43-48

[9] Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis [J].

Chen, JS ;

Witzmann, KA ;

Spilker, T ;

Fink, RJ ;

LiPuma, JJ .

JOURNAL OF PEDIATRICS, 2001, 139 (05) :643-649

[10]

*CYST FIBR FDN, 1998, PAT REG 1997 ANN REP

← 1 2 3 4 5 →